These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 14593743)

  • 1. The peptidyl-prolyl isomerase Pin1.
    Joseph JD; Yeh ES; Swenson KI; Means AR; Winkler
    Prog Cell Cycle Res; 2003; 5():477-87. PubMed ID: 14593743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins.
    Shen M; Stukenberg PT; Kirschner MW; Lu KP
    Genes Dev; 1998 Mar; 12(5):706-20. PubMed ID: 9499405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Unexpected roles of the peptidyl-prolyl cis/trans isomerase Pin1].
    Lavoie SB; Albert AL; Vincent M
    Med Sci (Paris); 2003 Dec; 19(12):1251-8. PubMed ID: 14691750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1.
    Crenshaw DG; Yang J; Means AR; Kornbluth S
    EMBO J; 1998 Aug; 17(5):1315-27. PubMed ID: 9482729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pin1: a therapeutic target in Alzheimer neurodegeneration.
    Hamdane M; Smet C; Sambo AV; Leroy A; Wieruszeski JM; Delobel P; Maurage CA; Ghestem A; Wintjens R; Bégard S; Sergeant N; Delacourte A; Horvath D; Landrieu I; Lippens G; Buée L
    J Mol Neurosci; 2002 Dec; 19(3):275-87. PubMed ID: 12540053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism.
    Zhou XZ; Lu PJ; Wulf G; Lu KP
    Cell Mol Life Sci; 1999 Nov; 56(9-10):788-806. PubMed ID: 11212339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of phosphatase inhibitor-2 to prolyl isomerase Pin1 modifies specificity for mitotic phosphoproteins.
    Li M; Stukenberg PT; Brautigan DL
    Biochemistry; 2008 Jan; 47(1):292-300. PubMed ID: 18062707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pin1 as an anticancer drug target.
    Xu GG; Etzkorn FA
    Drug News Perspect; 2009 Sep; 22(7):399-407. PubMed ID: 19890497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent advances in the study of pin1 and its inhibitors].
    Zhang CJ; Zhang ZH; Xu BL; Wang YL
    Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers].
    Marsolier J; Weitzman JB
    Med Sci (Paris); 2014; 30(8-9):772-8. PubMed ID: 25174754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
    Ryo A; Liou YC; Lu KP; Wulf G
    J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of the prolyl isomerase Pin1 for the replication checkpoint.
    Winkler KE; Swenson KI; Kornbluth S; Means AR
    Science; 2000 Mar; 287(5458):1644-7. PubMed ID: 10698738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peptidyl-prolyl isomerase Pin1 regulates cytokinesis through Cep55.
    van der Horst A; Khanna KK
    Cancer Res; 2009 Aug; 69(16):6651-9. PubMed ID: 19638580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human peptidyl-prolyl isomerase essential for regulation of mitosis.
    Lu KP; Hanes SD; Hunter T
    Nature; 1996 Apr; 380(6574):544-7. PubMed ID: 8606777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl isomerase Pin1 in cancer.
    Lu Z; Hunter T
    Cell Res; 2014 Sep; 24(9):1033-49. PubMed ID: 25124924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pin1 acts as a negative regulator of the G2/M transition by interacting with the Aurora-A-Bora complex.
    Lee YC; Que J; Chen YC; Lin JT; Liou YC; Liao PC; Liu YP; Lee KH; Lin LC; Hsiao M; Hung LY; Huang CY; Lu PJ
    J Cell Sci; 2013 Nov; 126(Pt 21):4862-72. PubMed ID: 23970419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease.
    Takahashi K; Uchida C; Shin RW; Shimazaki K; Uchida T
    Cell Mol Life Sci; 2008 Feb; 65(3):359-75. PubMed ID: 17965833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease.
    Rostam MA; Piva TJ; Rezaei HB; Kamato D; Little PJ; Zheng W; Osman N
    Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):117-24. PubMed ID: 25377120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells.
    Eckerdt F; Yuan J; Saxena K; Martin B; Kappel S; Lindenau C; Kramer A; Naumann S; Daum S; Fischer G; Dikic I; Kaufmann M; Strebhardt K
    J Biol Chem; 2005 Nov; 280(44):36575-83. PubMed ID: 16118204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Peptidyl-Prolyl
    Anto NP; Muraleedharan A; Nath PR; Sun Z; Keasar C; Livneh E; Braiman A; Altman A; Kong KF; Isakov N
    Front Immunol; 2023; 14():1126464. PubMed ID: 36969236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.